Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00450372
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:18.171863+00:00
Published At
2013-05-01T00:00:00+00:00
Record Updated At
2017-02-08
Results Posted At
2013-05-01
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Melanoma (Skin)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-02-08"
protocolSection.identificationModule.nctId
"NCT00450372"
protocolSection.identificationModule.officialTitle
"Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2013-05-01"

Study condition terms

  • Melanoma (Skin) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.